Market News

Etrade Capital Management Has Cut Dr Pepper Snapple Group (DPS) Position; Needham Investment Management Trimmed Thermo Fisher Scientific (TMO) Stake

Etrade Capital Management Llc decreased Dr Pepper Snapple Group Inc (DPS) stake by 41.8% reported in 2017Q3 SEC filing. Etrade Capital Management Llc sold 3,639 shares as Dr Pepper Snapple Group Inc (DPS)’s stock declined 3.26%. The Etrade Capital Management Llc holds 5,067 shares with $448,000 value, down from 8,706 last quarter. Dr Pepper Snapple Group Inc now has $17.20B valuation. The stock decreased 0.42% or $0.4 during the last trading session, reaching $95.24. About 853,241 shares traded. Dr Pepper Snapple Group, Inc. (NYSE:DPS) has declined 1.39% since January 14, 2017 and is downtrending. It has underperformed by 18.09% the S&P500.

Needham Investment Management Llc decreased Thermo Fisher Scientific Inc (TMO) stake by 2.12% reported in 2017Q3 SEC filing. Needham Investment Management Llc sold 2,000 shares as Thermo Fisher Scientific Inc (TMO)’s stock rose 8.13%. The Needham Investment Management Llc holds 92,500 shares with $17.50M value, down from 94,500 last quarter. Thermo Fisher Scientific Inc now has $84.28 billion valuation. The stock increased 0.72% or $1.51 during the last trading session, reaching $210.17. About 1.49 million shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 15.57% since January 14, 2017 and is uptrending. It has underperformed by 1.13% the S&P500.

Among 20 analysts covering Dr Pepper Snapple (NYSE:DPS), 11 have Buy rating, 0 Sell and 9 Hold. Therefore 55% are positive. Dr Pepper Snapple had 62 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Monday, May 1 by Barclays Capital. The stock has “Hold” rating by Deutsche Bank on Friday, October 23. Jefferies maintained Dr Pepper Snapple Group, Inc. (NYSE:DPS) on Monday, August 7 with “Buy” rating. The company was upgraded on Monday, October 5 by Evercore. The firm has “Neutral” rating given on Friday, July 28 by UBS. The stock of Dr Pepper Snapple Group, Inc. (NYSE:DPS) has “Hold” rating given on Friday, May 26 by Susquehanna. On Tuesday, May 16 the stock rating was upgraded by Morgan Stanley to “Overweight”. On Thursday, January 4 the stock rating was maintained by Jefferies with “Buy”. The stock of Dr Pepper Snapple Group, Inc. (NYSE:DPS) earned “Sell” rating by Goldman Sachs on Wednesday, January 13. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, August 31.

Analysts await Dr Pepper Snapple Group, Inc. (NYSE:DPS) to report earnings on February, 13. They expect $1.17 earnings per share, up 12.50% or $0.13 from last year’s $1.04 per share. DPS’s profit will be $211.24M for 20.35 P/E if the $1.17 EPS becomes a reality. After $1.10 actual earnings per share reported by Dr Pepper Snapple Group, Inc. for the previous quarter, Wall Street now forecasts 6.36% EPS growth.

Etrade Capital Management Llc increased General Mills Inc (NYSE:GIS) stake by 6,904 shares to 60,555 valued at $3.14M in 2017Q3. It also upped Glaxosmithkline Plc (NYSE:GSK) stake by 13,994 shares and now owns 119,400 shares. Facebook Inc (NASDAQ:FB) was raised too.

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on January, 30. They expect $2.66 earnings per share, up 10.37% or $0.25 from last year’s $2.41 per share. TMO’s profit will be $1.07 billion for 19.75 P/E if the $2.66 EPS becomes a reality. After $2.31 actual earnings per share reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts 15.15% EPS growth.

Investors sentiment increased to 0.96 in 2017 Q3. Its up 0.05, from 0.91 in 2017Q2. It is positive, as 51 investors sold TMO shares while 383 reduced holdings. 77 funds opened positions while 339 raised stakes. 333.20 million shares or 3.09% more from 323.23 million shares in 2017Q2 were reported. First Bank & Trust reported 25,593 shares. Main Street Rech Ltd Liability Com has 0.05% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). Cim Inv Mangement has invested 0.24% in Thermo Fisher Scientific Inc. (NYSE:TMO). Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.35% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO) for 198,891 shares. 185,156 are held by Spears Abacus Advsr Ltd Liability Company. Dt Investment Lc invested in 1,065 shares or 0.03% of the stock. Westfield Capital Mngmt Com Limited Partnership holds 0.04% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO) for 30,211 shares. 8,670 are held by Regent Investment Management Ltd Liability. Gm Advisory Grp Inc stated it has 1,296 shares or 0.07% of all its holdings. Sol Capital Mngmt owns 3,309 shares or 0.18% of their US portfolio. Kentucky Retirement, a Kentucky-based fund reported 24,021 shares. Moreno Evelyn V holds 1,739 shares. M holds 4,162 shares or 0.25% of its portfolio. Alpine Woods Cap Investors Ltd invested in 0.83% or 86,250 shares. Karp Mgmt invested in 6,125 shares or 0.54% of the stock.

Since August 2, 2017, it had 0 buys, and 7 selling transactions for $18.71 million activity. The insider CASPER MARC N sold $9.59M. The insider MANZI JIM P sold $1.96M. Another trade for 30,000 shares valued at $5.28 million was made by Herrema Gregory J. on Wednesday, August 2. Shine Daniel P sold $366,645 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday, August 30. Another trade for 3,894 shares valued at $721,091 was sold by HORNSTRA PETER E. HARRIS C MARTIN also sold $65,149 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday, August 30. $736,092 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) was sold by HOOGASIAN SETH H.

Among 18 analysts covering Thermo Fisher Scientific (NYSE:TMO), 17 have Buy rating, 0 Sell and 1 Hold. Therefore 94% are positive. Thermo Fisher Scientific had 53 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Tuesday, June 6 with “Hold”. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Buy” rating given on Thursday, January 7 by Deutsche Bank. Robert W. Baird maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Monday, October 2. Robert W. Baird has “Buy” rating and $194.0 target. The stock has “Buy” rating by Cowen & Co on Friday, September 8. The stock has “Buy” rating by Barclays Capital on Monday, September 25. Argus Research initiated the shares of TMO in report on Tuesday, October 6 with “Buy” rating. Jefferies maintained the shares of TMO in report on Friday, October 20 with “Hold” rating. As per Monday, January 11, the company rating was maintained by Stifel Nicolaus. The rating was maintained by Robert W. Baird on Monday, October 23 with “Buy”. BTIG Research reinitiated it with “Buy” rating and $180 target in Friday, July 22 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *